Another cohort study from China indicated that decreased blood calcium levels at initial care associated with an increased risk of BM versus normal levels in 2012.[23] Besides, in 2014, Lee et al[28] showed that increased serum CEA levels could be a predictor of increased bone metastatic potential in stage IV lung cancers. This evidence concerns the gene CEACAM5 and lung cancer.